Research Seminar: Do remedies hurt the performance of M&As? Evidence from M&As scrutinized by the EU competition authority.
Nazarbayev University Graduate School of Business invites you to the Research Seminar titled “Do remedies hurt the performance of M&As? Evidence from M&As scrutinized by the EU competition authority”, presented by Valentina Fani.
Abstract
This study examines the performance implications of remedies adopted during the investigation of Mergers & Acquisitions by the competition authority. The adoption of remedies in M&As is a prevalent phenomenon that has received little attention. Remedies can involve the loss of ownership (i.e., structural remedies) or limit the control (i.e., behavioral remedies) over some of the firm assets. We argue that the adoption of remedies risks diminishing the market power effects of M&As. Yet, the loss of control over some assets can create opportunities for reshaping the business landscape and significantly enhance acquisition performance. Analyses of data on a sample of 1714 M&As examined by the European Commission show overall a positive relationship between remedies and acquisition performance.
Time: 6 pm - 7 pm
Area: Strategy
Add to your calendar
Valentina Fani
Ph.D. candidate in the Strategy, Globalization and Society department at HEC Lausanne
Valentina Fani is a Ph.D. candidate in the Strategy, Globalization and Society department at HEC Lausanne (Switzerland). Her doctoral thesis aims to provide new insights on corporate strategy, with a particular interest in the intersection of mergers & acquisitions, competition, and competition policy.
Date:
Time:
Location:
